Literature DB >> 1463662

Characterization of an elastase from aneurysmal aorta which degrades intact aortic elastin.

J M Reilly1, C M Brophy, M D Tilson.   

Abstract

Accumulating evidence suggests that abdominal aortic aneurysms (AAA) are due to a pathologic process which results in the destruction of aortic elastin and other matrix components. In this study, protein extractions were performed on both aneurysmal and normal aorta. Extracts were applied to frozen section of normal aorta either alone or in combination with 10 mM ethylenediaminetetraacetic acid, recombinant tissue inhibitor of metalloproteases, 10 mM zinc, and 5 mM phenylmethylsulfonyl fluoride, under conditions where calcium was removed from the buffer. After incubation, the sections were stained for elastin and evaluated by computerized morphometry. Aneurysm extracts, only in the presence of calcium, showed significant elastolytic activity characterized by destruction of intact elastic lamellae that was inhibited by ethylenediaminetetraacetic acid, the recombinant metalloprotease inhibitor, and zinc. Phenylmethylsulfonyl fluoride showed no inhibitory activity. Healthy aortic extract showed no elastolytic activity. This inhibitory profile is consistent with a metalloenzyme. We conclude that aneurysmal aorta contains elastolytic activity that is secondary to a metalloenzyme which is not present in normal aorta. This activity may play a role in the destruction of the elastin matrix that is seen in AAA's.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1463662     DOI: 10.1007/BF02000820

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  8 in total

1.  Aneurysmal lesions of patients with abdominal aortic aneurysm contain clonally expanded T cells.

Authors:  Song Lu; John V White; Wan Lu Lin; Xiaoying Zhang; Charalambos Solomides; Kyle Evans; Nectaria Ntaoula; Ifeyinwa Nwaneshiudu; John Gaughan; Dimitri S Monos; Emilia L Oleszak; Chris D Platsoucas
Journal:  J Immunol       Date:  2014-04-21       Impact factor: 5.422

2.  Inhibition of matrix metalloproteinase activity attenuates tenascin-C production and calcification of implanted purified elastin in rats.

Authors:  N Vyavahare; P L Jones; S Tallapragada; R J Levy
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

3.  Autoimmunity in the Abdominal Aortic Aneurysm and its Association with Smoking.

Authors:  M David Tilson
Journal:  Aorta (Stamford)       Date:  2017-12-01

4.  Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages.

Authors:  R W Thompson; D R Holmes; R A Mertens; S Liao; M D Botney; R P Mecham; H G Welgus; W C Parks
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

5.  Aortic enlargement in chronic obstructive pulmonary disease (COPD) and emphysema: The Multi-Ethnic Study of Atherosclerosis (MESA) COPD study.

Authors:  Kana Fujikura; Alessandra Albini; R Graham Barr; Megha Parikh; Julia Kern; Eric Hoffman; Grant T Hiura; David A Bluemke; James Carr; João A C Lima; Erin D Michos; Antoinette S Gomes; Martin R Prince
Journal:  Int J Cardiol       Date:  2021-02-13       Impact factor: 4.164

Review 6.  Pathogenesis of abdominal aortic aneurysms: role of nicotine and nicotinic acetylcholine receptors.

Authors:  Zong-Zhuang Li; Qiu-Yan Dai
Journal:  Mediators Inflamm       Date:  2012-03-18       Impact factor: 4.711

7.  Clonally expanded alpha-chain T-cell receptor (TCR) transcripts are present in aneurysmal lesions of patients with Abdominal Aortic Aneurysm (AAA).

Authors:  Song Lu; John V White; Raquel I Judy; Lisa L Merritt; Wan Lu Lin; Xiaoying Zhang; Charalambos Solomides; Ifeyinwa Nwaneshiudu; John Gaughan; Dimitri S Monos; Emilia L Oleszak; Chris D Platsoucas
Journal:  PLoS One       Date:  2019-07-16       Impact factor: 3.240

Review 8.  Human autoimmune diseases are specific antigen-driven T-cell diseases: identification of the antigens.

Authors:  Chris D Platsoucas; Emilia L Oleszak
Journal:  Immunol Res       Date:  2007       Impact factor: 4.505

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.